Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Dow
McKesson
Moodys
McKinsey

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Meridian Medcl Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MERIDIAN MEDCL, and what generic alternatives to MERIDIAN MEDCL drugs are available?

MERIDIAN MEDCL has seven approved drugs.

There is one US patent protecting MERIDIAN MEDCL drugs.

There are four patent family members on MERIDIAN MEDCL drugs in four countries.

Summary for Meridian Medcl
International Patents:4
US Patents:1
Tradenames:7
Ingredients:7
NDAs:7

Drugs and US Patents for Meridian Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl Techn PRALIDOXIME CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 018986-001 Apr 26, 1983 RX Yes Yes   Start Trial   Start Trial
Meridian Medcl Techn SEIZALAM midazolam hydrochloride SOLUTION;INTRAMUSCULAR 209566-001 Sep 14, 2018 RX Yes Yes   Start Trial   Start Trial
Meridian Medcl ALSUMA sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022377-001 Jun 29, 2010 DISCN No No 7,811,254   Start Trial Y   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-002 Jun 19, 2003 RX Yes Yes   Start Trial   Start Trial
Meridian Medcl Techn ATROPEN atropine SOLUTION;INTRAMUSCULAR 017106-004 Sep 17, 2004 RX Yes Yes   Start Trial   Start Trial
Meridian Medcl Techn LIDOPEN lidocaine hydrochloride INJECTABLE;INJECTION 017549-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Harvard Business School
Express Scripts
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.